CymaBay shares soar on tri­al up­date; Lon­za opens mas­sive Texas fa­cil­i­ty ded­i­cat­ed to cell, gene ther­a­pies; In­ovio lines up $56M

→ Swiss drug man­u­fac­tur­er Lon­za wants to cash in on the ris­ing de­mand for cell and gene ther­a­pies, and it reck­ons Texas is the place to do it. On Tues­day, Lon­za cut the rib­bon at its ded­i­cat­ed cell-and-gene-ther­a­py man­u­fac­tur­ing fa­cil­i­ty in Pearland, Greater Hous­ton — the world’s largest at 300,000 square feet, the com­pa­ny says. The ful­ly in­te­grat­ed plant will of­fer man­u­fac­tur­ing ser­vices for every stage of drug de­vel­op­ment, from pre­clin­i­cal and clin­i­cal to com­mer­cial­iza­tion, some of which is al­ready un­der way. By the end of 2018, it is ex­pect­ed to be ful­ly op­er­a­tional with 200-plus full-time staff.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER